-
- Breast Cancer
Hernix 40mg (Neratinib): Targeted Therapy For her2 Positive Breast Cancer
- Hernix 40 mg, containing the active ingredientNeratinib, is a groundbreaking oral medication specifically designed for patients withearly-stage Targeted therapy for her2-positive breast cancer. It reduces the risk of cancer recurrence after initial treatments such as surgery or chemotherapy. As a tyrosine kinase inhibitor (TKI), Hernix targets and blocks specific proteins involved in cancer cell growth, helping prevent the spread and…
- Read more
